| |
Latest 10 SEC filings (by transaction date) for AXNX within the last 6 months | |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Oct 3/24 | Oct 2/24 | Keese Kari Leigh | Direct Ownership | Common Stock | S - Open market or private sale | -2,597 | $69.41 |
Oct 3/24 | Oct 2/24 | Keese Kari Leigh | Direct Ownership | Common Stock | S - Open market or private sale | -364 | $69.40 |
Jul 25/24 | Jul 24/24 | Cohen Raymond W | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -25,771 | |
Jul 25/24 | Jul 24/24 | Cohen Raymond W | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -78,125 | |
Jul 25/24 | Jul 24/24 | Cohen Raymond W | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 78,125 | $25.82 |
Jul 25/24 | Jul 24/24 | Cohen Raymond W | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 25,771 | $14.19 |
Feb 2/24 | Jan 31/24 | Sama Rinda | Direct Ownership | Performance-Based Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -17,500 | |
Feb 2/24 | Jan 31/24 | Sama Rinda | Direct Ownership | Performance-Based Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -10,500 | |
Feb 2/24 | Jan 31/24 | Sama Rinda | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 28,000 | |
Feb 2/24 | Jan 31/24 | Noblett Karen | Direct Ownership | Performance-Based Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for AXNX within the last 6 months | |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Oct 3/24 | Oct 2/24 | Keese Kari Leigh | Direct Ownership | Common Stock | S - Open market or private sale | -2,597 | $69.41 |
Oct 3/24 | Oct 2/24 | Keese Kari Leigh | Direct Ownership | Common Stock | S - Open market or private sale | -364 | $69.40 |
Jul 25/24 | Jul 24/24 | Cohen Raymond W | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -25,771 | |
Jul 25/24 | Jul 24/24 | Cohen Raymond W | Direct Ownership | Stock Option (Right to Buy) | M - Exercise or conversion exempt under rule 16b-3 | -78,125 | |
Jul 25/24 | Jul 24/24 | Cohen Raymond W | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 78,125 | $25.82 |
Jul 25/24 | Jul 24/24 | Cohen Raymond W | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 25,771 | $14.19 |
Feb 2/24 | Jan 31/24 | Sama Rinda | Direct Ownership | Performance-Based Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -17,500 | |
Feb 2/24 | Jan 31/24 | Sama Rinda | Direct Ownership | Performance-Based Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -10,500 | |
Feb 2/24 | Jan 31/24 | Sama Rinda | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 28,000 | |
Feb 2/24 | Jan 31/24 | Noblett Karen | Direct Ownership | Performance-Based Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -15,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Stryker (N:SYK) |
Glaukos (N:GKOS) |
Inspire Medical Systems (N:INSP) |